L3VLUP
ProSign in

LIVN · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

LIVNLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • LIVN
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterLIVNLLY
Q3 20207 holders, $358m33 holders, $14.1bn
Q4 20205 holders, $373m29 holders, $17.3bn
Q1 20213 holders, $390m24 holders, $23.0bn
Q2 20216 holders, $550m24 holders, $27.8bn
Q3 20219 holders, $674m31 holders, $29.9bn
Q4 20218 holders, $753m31 holders, $34.7bn
Q1 20226 holders, $662m24 holders, $35.3bn
Q2 20227 holders, $563m33 holders, $42.7bn
Q3 20225 holders, $330m31 holders, $43.4bn
Q4 20226 holders, $222m31 holders, $46.6bn
Q1 20237 holders, $99m33 holders, $44.3bn
Q2 20237 holders, $204m37 holders, $59.6bn
Q3 20236 holders, $293m44 holders, $67.6bn
Q4 20237 holders, $300m45 holders, $73.6bn
Q1 20246 holders, $290m41 holders, $95.3bn
Q2 20247 holders, $364m43 holders, $110bn
Q3 20249 holders, $465m45 holders, $107bn
Q4 202413 holders, $457m46 holders, $93.9bn
Q1 20259 holders, $332m42 holders, $98.4bn
Q2 20257 holders, $332m43 holders, $93.2bn
Q3 20256 holders, $390m39 holders, $86.7bn
Q4 20258 holders, $673m41 holders, $123bn
Q1 20267 holders, $491m39 holders, $106bn
Q2 20266 holders, $583m44 holders, $132bn
LIVN

Livanova PLC

Holders
6
Reported value
$583m
Buyers
13
Sellers
17

Breadth -4 among 91 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
44
Reported value
$132bn
Buyers
24
Sellers
24

Breadth 0 among 91 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2026

Among the 45 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only LIVN (1)

Winton Group Ltd

Only LLY (39)

Acadian Asset Management LLC, AllianceBernstein LP, ARK Investment Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Discovery Capital Management LLC, Dodge & Cox, Fidelity (FMR LLC), Freestone Grove Partners LP, GAMCO Investors Inc, Glenview Capital Management LLC, Harris Associates LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Man Group PLC, Marshall Wace LLP, MFS Investment Management, and 14 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →